Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Heron Therapeutics Inc (NASDAQ: HRTX) closed at $1.99 in the last session, down -2.93% from day before closing price of $2.05. In other words, the price has decreased by -$2.93 from its previous closing price. On the day, 1.69 million shares were traded. HRTX stock price reached its highest trading level at $2.14 during the session, while it also had its lowest trading level at $1.985.
Ratios:
We take a closer look at HRTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.85 and its Current Ratio is at 2.38.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 13, 2024, initiated with a Buy rating and assigned the stock a target price of $7.
On April 23, 2024, CapitalOne started tracking the stock assigning a Overweight rating and target price of $6.
Needham reiterated its Buy rating for the stock on March 13, 2024, while the target price for the stock was revised from $4 to $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 17 ’23 when Forbes William P bought 25,000 shares for $1.09 per share. The transaction valued at 27,250 led to the insider holds 79,000 shares of the business.
Forbes William P bought 50,000 shares of HRTX for $46,995 on Nov 16 ’23. The EVP, Chief Development Officer now owns 54,000 shares after completing the transaction at $0.94 per share. On Nov 16 ’23, another insider, Collard Craig A, who serves as the Chief Executive Officer of the company, bought 150,000 shares for $0.92 each. As a result, the insider paid 137,970 and bolstered with 186,496 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HRTX now has a Market Capitalization of 301819328 and an Enterprise Value of 413184352. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.21. Its current Enterprise Value per Revenue stands at 3.03 whereas that against EBITDA is -15.879.
Stock Price History:
Over the past 52 weeks, HRTX has reached a high of $3.93, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is -10.35%, while the 200-Day Moving Average is calculated to be -23.41%.
Shares Statistics:
According to the various share statistics, HRTX traded on average about 2.44M shares per day over the past 3-months and 2661180 shares per day over the past 10 days. A total of 150.29M shares are outstanding, with a floating share count of 144.09M. Insiders hold about 5.00% of the company’s shares, while institutions hold 81.30% stake in the company. Shares short for HRTX as of 1726185600 were 35441558 with a Short Ratio of 14.54, compared to 1723680000 on 35961755. Therefore, it implies a Short% of Shares Outstanding of 35441558 and a Short% of Float of 30.209999999999997.
